30.01.2020 12:38:55
|
Alexion Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates
(RTTNews) - Below are the earnings highlights for Alexion Pharmaceuticals Inc. (ALXN):
-Earnings: $889.0 million in Q4 vs. -$45.0 million in the same period last year. -EPS: $4.00 in Q4 vs. -$0.20 in the same period last year. -Excluding items, Alexion Pharmaceuticals Inc. reported adjusted earnings of $611.0 million or $2.71 per share for the period. -Analysts projected $2.60 per share -Revenue: $1.38 billion in Q4 vs. $1.13 billion in the same period last year.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Alexion Pharmaceuticals Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |